United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024

Report Sellers has added a new market research report “United States flu vaccine market” to its offerings. The report is an in-depth market study providing accurate market insights including the latest trends, forecast, competitive insights, etc.

Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.

Long–term Growth Projection and Development:

• Sanofi to Acquire Protein Sciences Corporation
• It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024.
• Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season
• It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024
• BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine

“Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an in-depth analysis of the flu vaccination pattern in both Children and Adults in the United States. It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand, and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations, and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the US flu vaccine market such as Sanofi Pasteur, GSK, and Seqirus. The major market players are evaluated on various parameters such as company overview, product outlook, latest development & trends and sales analysis of flu vaccine market from 2011 to 2022. The report also entails major drivers and inhibitors in the US flu vaccine market.

Browse through the complete description and in-depth TOC on “United States flu vaccine market”
https://www.reportsellers.com/market-research-report/flu-vaccine-market

Key Companies Covered in this Report:

• Seqirus
• Sanofi Pasteur
• GlaxoSmithKline(GSK)

Request Sample here: https://www.reportsellers.com/market-research-report/flu-vaccine-market

Related Reports
https://www.reportsellers.com/market-research-report/Global-Squalene-Market-Outlook-2017-2022
https://www.reportsellers.com/market-research-report/Global-Vinpocetine-Market-Research-Report-2017
https://www.reportsellers.com/market-research-report/Global-Squalane-Market-Outlook-2017-2022

We have a large number of reports in other Pharmaceuticals Industry which can be accessed in the following link:
https://www.reportsellers.com/sub-category/Pharmaceuticals-market-research-report

About Report Sellers
Report Sellers is a premium market research service provider offering market reports in varied sectors. We have a team of experienced analysts and publishers who continuously track the latest trends in different industries.

Report Sellers is a brand of global repute and offers the best-suited research services to its clients globally in the most satisfying manner. We have a strong network of industry experts who have successfully delivered complex research assignments in niche and top markets.

For more information, contact
Aditya Joshi
Report Sellers
Email: sales@reportsellers.com
Direct: +1-214-396-2385